跳至主要内容
临床试验/CTRI/2025/08/093080
CTRI/2025/08/093080尚未招募2/3 期

"RANDOMIZED CONTROLLED CLINICAL TRIAL TP STUDY THE EFFICACY OF SAHACHAR, NIMB, PATHA, PATOL KWATH YONIDHAWAN IN THE MANAGEMENT OF KAPHAJ YONIVYAPAD"

DrShubhangi Gajanan Mulange1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年8月24日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Decreased In Yonigat Strava, Yonigat Kandu, Yonigat Vedana.

研究概览

简要总结

Need has always been felt to develop certain Ayurvedic treatment modalities for

the management of Kaphaj Yonivyapad and vaginal candidiasis which could be safe,

effective, readily available, cost effective, without any side effects in comparison to

the therapeutic procedures of different systems of medicine. There is Need to maintain womens health for this Sahachara, Nimb, Patha, Patol

kwath are used they have properties like Kaphashamak, Kandughana, Krimighana,

Stambhak, Vranaropak, Antiseptic. Because of these properties it helps to overcome

the symptoms of Kaphaj Yonivyapad it may increase local immunity there by prevent

recurrence of symptoms in patients. In other pathy drug generally have minor, major side effect it may be due to

prolong use of that drug but, in ayurvedic formulation has minimum side effects.

hence selection of appropriate treatment without disturbing other systems are used.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Married women of Age between 20-45 Years
  • Shweta strav
  • Alpavedana.

排除标准

  • Pregnant Women
  • Patients with Diabetes, Sexually Transmitted Disease, HIV, Gonorrhea, malignancies, Carcinoma of cervix, Pelvic Inflammatory Disease, IUCD, patient on
  • Patient not willing to give informed consent
  • Unexplained vaginal bleeding — occasionally and intermitted.

结局指标

主要结局

Decreased In Yonigat Strava, Yonigat Kandu, Yonigat Vedana.

时间窗: 7 days

次要结局

  • Significant Decreased In Signs and Symptoms Yonigat Strava, Yonigat Kandu, Yonigat Vedana.(1 month)

研究者

发起方
DrShubhangi Gajanan Mulange
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Shubhangi Gajanan Mulange

Ayurvedic Medical College and Hospital PG Institue And Reserch Center Uran Islampur Sangli

研究点 (1)

Loading locations...

相似试验